These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8592021)
41. Time for new long-term trials of postmenopausal hormone therapies! MacLennan A; Sturdee DW Climacteric; 2003 Dec; 6(4):265-7. PubMed ID: 15006246 [No Abstract] [Full Text] [Related]
42. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896 [TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy: current controversies. Davison S; Davis SR Clin Endocrinol (Oxf); 2003 Mar; 58(3):249-61. PubMed ID: 12608928 [TBL] [Abstract][Full Text] [Related]
44. Risk assessment of the menopausal patient. Kothari S; Thacker HL Med Clin North Am; 1999 Nov; 83(6):1489-502. PubMed ID: 10584604 [TBL] [Abstract][Full Text] [Related]
45. Postmenopausal hormone therapy: have HERS2 and WHI given us any new information? Fylstra DL J S C Med Assoc; 2002 Dec; 98(8):299-304. PubMed ID: 12532655 [TBL] [Abstract][Full Text] [Related]
46. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health. Gambacciani M; Genazzani AR Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071 [No Abstract] [Full Text] [Related]
47. Clinical practice. Postmenopausal hormone-replacement therapy. Manson JE; Martin KA N Engl J Med; 2001 Jul; 345(1):34-40. PubMed ID: 11439947 [No Abstract] [Full Text] [Related]
48. Breast cancer risk during hormone therapy: experimental versus clinical data. Ruan X; Seeger H; Mueck AO Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615 [TBL] [Abstract][Full Text] [Related]
49. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
51. Estrogen replacement in menopausal women: recent and current prospective studies, the WHI and the KEEPS. Harman SM Gend Med; 2006 Dec; 3(4):254-69. PubMed ID: 17582367 [TBL] [Abstract][Full Text] [Related]
52. Hormone replacement grows; some experts worried. Blume E J Natl Cancer Inst; 1996 May; 88(10):637-9. PubMed ID: 8627638 [No Abstract] [Full Text] [Related]
53. Weighing the risks and benefits of hormone therapy. Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505 [No Abstract] [Full Text] [Related]
54. Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages? Sobel NB Obstet Gynecol Clin North Am; 1994 Jun; 21(2):299-319. PubMed ID: 7936546 [TBL] [Abstract][Full Text] [Related]
55. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases]. Higuchi T; Mizunuma H Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136 [TBL] [Abstract][Full Text] [Related]